NCT00312104 - Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes | Biotech Hunter

Enrollment

325

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

DRUG

insulin glargine

DRUG

insulin aspart

Trial Locations (46)

1030

Novo Nordisk Investigational Site, Vienna

1090

Novo Nordisk Investigational Site, Vienna

2193

Novo Nordisk Investigational Site, Johannesburg

4091

Novo Nordisk Investigational Site, Durban

7130

Novo Nordisk Investigational Site, Cape Town

7925

Novo Nordisk Investigational Site, Cape Town

8036

Novo Nordisk Investigational Site, Graz

10789

Novo Nordisk Investigational Site, Berlin

16761

Novo Nordisk Investigational Site, Hennigsdorf

19049

Novo Nordisk Investigational Site, Schwerin

20251

Novo Nordisk Investigational Site, Hamburg

24105

Novo Nordisk Investigational Site, Kiel

24939

Novo Nordisk Investigational Site, Flensburg

30171

Novo Nordisk Investigational Site, Hanover

33378

Novo Nordisk Investigational Site, Rheda-Wiedenbrück

37154

Novo Nordisk Investigational Site, Northeim

39218

Novo Nordisk Investigational Site, Schönebeck

39307

Novo Nordisk Investigational Site, Genthin

41061

Novo Nordisk Investigational Site, Mönchengladbach

41460

Novo Nordisk Investigational Site, Neuss

45138

Novo Nordisk Investigational Site, Essen

45770

Novo Nordisk Investigational Site, Marl

46569

Novo Nordisk Investigational Site, Hünxe

53474

Novo Nordisk Investigational Site, Bad Neuenahr-Ahrweiler

55270

Novo Nordisk Investigational Site, Schwabenheim

55545

Novo Nordisk Investigational Site, Bad Kreuznach

60590

Novo Nordisk Investigational Site, Frankfurt

65183

Novo Nordisk Investigational Site, Wiesbaden

65582

Novo Nordisk Investigational Site, Diez

66121

Novo Nordisk Investigational Site, Saarbrücken

66299

Novo Nordisk Investigational Site, Friedrichsthal

66333

Novo Nordisk Investigational Site, Völklingen

66538

Novo Nordisk Investigational Site, Neunkirchen

66740

Novo Nordisk Investigational Site, Saarlouis

66780

Novo Nordisk Investigational Site, Rehlingen-Siersburg

67059

Novo Nordisk Investigational Site, Ludwigshafen

69115

Novo Nordisk Investigational Site, Heidelberg

76829

Novo Nordisk Investigational Site, Landau

90402

Novo Nordisk Investigational Site, Nuremberg

91052

Novo Nordisk Investigational Site, Erlangen

97072

Novo Nordisk Investigational Site, Würzburg

97980

Novo Nordisk Investigational Site, Bad Mergentheim

A 1160

Novo Nordisk Investigational Site, Vienna

A-1130

Novo Nordisk Investigational Site, Vienna

06120

Novo Nordisk Investigational Site, Halle

07743

Novo Nordisk Investigational Site, Jena